Uniphar’s acquisition of Irish-headquartered pharmacy solutions business NaviCorp is to be investigated by the Competition and Consumer Protection Commission .
The deals were expected to deliver a return on capital employed to the group in line with Uniphar’s target rate of 12-15 per cent within three years.
IrishTimes So what if the final incarnation refuses to deal with the government on pharmaceutical pricing?
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
State records €3.5bn budget surplus in final quarter of 2021 | Business PostState records €3.5bn budget surplus in final quarter of 2021, taaffems reports.
اقرأ أكثر »
Uniphar wins Company of the Year at Irish Times Business AwardsIrish-listed healthcare group defied Covid-19 pandemic to deliver a 31% surge in profits
اقرأ أكثر »